Back to List View Graph View

Radiation therapy

Radiation therapy is a major cancer treatment modality that uses ionizing radiation to damage cellular DNA and other critical biomolecules, thereby inhibiting tumor growth and inducing cell death.

Where the papers sit

39 papers from the last 6 months study radiation therapy directly · updated from PubMed 16 Nov 2026

  • Radiotherapy and Tumor Immunity

    Radiotherapy is increasingly combined with immune checkpoint blockade, targeted inhibitors, and immune-reprogramming delivery systems rather than used alone. PD-1/PD-L1 signaling, CD200R-mediated macrophage suppression, and transforming growth factor pathways recur as barriers to antitumor immunity. METTL14/Wnt9a/β-catenin and UFMylation inhibition, GSDME-mediated pyroptosis, and chemokine decoys are proposed ways to improve response. Virtual tumors and nanovesicles push the field toward personalized combination selection and targeted delivery, but durable benefit remains context-dependent.

    10 papers · 25.6%

  • Breast Radiotherapy Outcomes

    Breast radiotherapy is moving toward more individualized benefit estimates, dose-volume planning, and reconstruction-aware delivery. Hypofractionation and proton therapy are evaluated against acute skin reactions, cardiac exposure, and quality of life. Age, treatment volume, and margin selection recur as determinants of benefit and toxicity. Population data also examine second primary lung cancer and the lived burden of weakness and dizziness after treatment.

    9 papers · 23.1%

  • Multimodal Carcinoma Treatment

    Cisplatin-based chemoradiotherapy remains central for squamous carcinomas, while chemoimmunotherapy and surgery are being compared in advanced disease. NUT carcinoma reports emphasize multimodal treatment and durable responses in a small, heterogeneous population. Outcomes recur around progression-free survival, metastasis, and long-term follow-up rather than a single standard. Nutritional risk, fall risk, and cardiac-sparing planning broaden the focus toward survivorship and treatment tolerance.

    8 papers · 20.5%

  • Radiotherapy for Rare Tumors

    Radiotherapy decisions in rare tumors are shifting from uniform protocols toward risk-, subtype-, and timing-informed treatment. Ewing sarcoma analyses seek treatment-effect heterogeneity, while molecular subtype guides radiotherapy timing in infant medulloblastoma. Surgery, adjuvant radiation, chemotherapy, local control, survival, and late toxicity recur across sarcoma, spinal ependymoma, thymic malignancies, and brain tumors. Treatment interruptions and tumor oxygenation remain unresolved modifiers of benefit.

    7 papers · 17.9%

  • Prostate Cancer Radiotherapy

    High-dose radiotherapy is being paired with long-term androgen deprivation for high-risk prostate cancer, while hyperthermia is explored in ductal adenocarcinoma. Local treatment is increasingly judged against years of life lost, not survival alone. Radical prostatectomy and salvage radiotherapy remain competing routes, with prostate-specific antigen central to follow-up. The cluster is chiefly prostate-focused, with broader adenocarcinoma utilization studies adding context.

    5 papers · 12.8%

Papers

The 39 papers from the last 6 months that study radiation therapy directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Radiotherapy and Tumor Immunity (10)
  1. Radiation-induced CD200+ tumor-associated macrophages suppress eosinophil-mediated antitumor immunity through CD200R signaling in hepatocellular carcinoma. Cellular & molecular immunology · 13 Aug 2026 PMID 42595852
  2. Targeting the METTL14/Wnt9a/β-catenin pathway with pharmacological inhibitors enhances radiotherapy and immunotherapy efficacy in non-small cell lung cancer. European journal of pharmacology · 6 Aug 2026 PMID 42562044
  3. Biomimetic nanovesicle mediated GSDME delivery reprograms the tumor immune microenvironment via pyroptosis to enhance radiotherapy. Journal of controlled release : official journal of the Controlled Release Society · 23 Jul 2026 PMID 42492635
  4. Dual-targeting pharmacological UFMylation inhibition reprograms tumor and immune microenvironments to achieve long-term glioblastoma regression. Signal transduction and targeted therapy · 19 Jul 2026 PMID 42472853
  5. Radiosensitization effect of PD-L1-targeted small molecules with direct antitumor activity on non-small cell lung Cancer. Bioorganic chemistry · 14 Jul 2026 PMID 42447749
  6. Hijacking radiotherapy-induced chemokines with self-assembled molecular decoys for glioblastoma radio-immunotherapy. Journal of controlled release : official journal of the Controlled Release Society · 2 Jul 2026 PMID 42392408
  7. Camrelizumab, Apatinib, and Radiotherapy in Locally Advanced, Unresectable Hepatocellular Carcinoma: A Phase II Study. Clinical cancer research : an official journal of the American Association for Cancer Research · 30 Jun 2026 PMID 42377073
  8. Aptamer-tagged exosome-coated Bismuth ferrite-mesoporous silica nanoparticle for chemoradiotherapy and CT/MR imaging of non-small cell lung cancer. International journal of biological macromolecules · 24 Jun 2026 PMID 42342170
  9. Virtual Tumors Enable Prediction of Personalized Therapeutic Combinations for Non-Small Cell Lung Cancer. Cancer research · 24 Jun 2026 PMID 42341181
  10. Immune Checkpoint Blockade Augments Lymphodepleting Chemotherapy-Induced Antitumor Immunity by Expanding Effector CD8+ T-cell Clones. Cancer research · 22 Jun 2026 PMID 42329854
Breast Radiotherapy Outcomes (9)
  1. "After radiation sessions, I sometimes feel weak and dizzy'': Experiences of Ghanaian women with breast cancer post radiotherapy. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 6 Oct 2026 PMID 42836877
  2. Maskless head and neck radiotherapy using surface-guided radiation therapy: initial clinical feasibility of real-time setup, intrafraction monitoring, and automatic beam-hold. Journal of applied clinical medical physics · 26 Sept 2026 PMID 42798136
  3. Study of Adaptive Radiotherapy for High-Grade Glioma Based on Interfraction MRI. Cancer medicine · 1 Sept 2026 PMID 42675793
  4. Should breast/thoracic wall and lymph node volumes have the same margin in hypofractionated radiotherapy? Biomedical physics & engineering express · 28 Aug 2026 PMID 42664997
  5. Does Breast Reconstruction Affect Radiation Therapy? Examining Device Type, Placement, and Dose Effects. Plastic and reconstructive surgery · 28 Jul 2026 PMID 42519937
  6. Age-dependent relative and absolute benefit of radiotherapy after breast-conserving surgery: a population-based analysis using SEER data. Breast cancer research and treatment · 23 Jul 2026 PMID 42493682
  7. Associations Between Cardiac Radiation Dose-Volume Metrics and Health-Related Quality of Life for Patients With Breast Cancer on the RadComp Trial. International journal of radiation oncology, biology, physics · 21 Jul 2026 PMID 42479004
  8. Comparative Analysis of Acute Skin Reactions After Postmastectomy Photon and Intensity Modulated Proton Therapy. International journal of radiation oncology, biology, physics · 10 Jun 2026 PMID 42269789
  9. Impact of adjuvant breast radiotherapy on the risk and the survival of second primary lung cancer: a large population-based study. Japanese journal of clinical oncology · 2 Jun 2026 PMID 42228854
Multimodal Carcinoma Treatment (8)
  1. Perception of fall risk among cancer survivors receiving Radiotherapy/Chemotherapy in China: A latent profile analysis. PloS one · 24 Sept 2026 PMID 42784562
  2. Transoral Robotic Surgery (TORS) versus radical radiotherapy following neoadjuvant therapy for oropharyngeal carcinoma: a multicenter, real-world efficacy and safety analysis. Journal of robotic surgery · 19 Sept 2026 PMID 42762275
  3. Nasal NUT carcinoma with repeated responses during multimodal treatment incorporating radiotherapy: A case report. Medicine · 19 Sept 2026 PMID 42760727
  4. Radiotherapy in Thoracic NUT Carcinoma: A Pooled Analysis of Long-term Survivors and Clinical Outcome Heterogeneity. Archivos de bronconeumologia · 16 Sept 2026 PMID 42749595
  5. Cisplatin enhances radiation-induced apoptosis in peripheral lymphocytes of cancer patients: in vivo and in vitro findings. Radiation oncology (London, England) · 6 Sept 2026 PMID 42701199
  6. Pretreatment Geriatric Nutritional Risk Index in RADPLAT-treated Patients With Oral Squamous Cell Carcinoma: A Pilot Study. In vivo (Athens, Greece) · 28 Aug 2026 PMID 42665408
  7. Efficacy analysis of first-line chemoimmunotherapy with or without radiotherapy in stage IVB esophageal squamous cell carcinoma: a real-world study. Future oncology (London, England) · 27 Jul 2026 PMID 42504461
  8. A modality-agnostic coronary artery habitat model for cardiac sparing in radiotherapy. Medical physics · 22 Jul 2026 PMID 42482440
Radiotherapy for Rare Tumors (7)
  1. Psychosocial Distress and Radiation Treatment Interruptions in Patients With Cancer Using Machine Learning and Regression: Retrospective Cohort Study. JMIR cancer · 19 Oct 2026 PMID 42896154
  2. Oxygenation and Spatial Heterogeneity Shape Radiotherapy Protocol Ranking Through Phenotypic Adaptation. Bulletin of mathematical biology · 3 Oct 2026 PMID 42829426
  3. Long-term outcomes after adjuvant radiotherapy in adult spinal ependymomas: a multicenter study by the trod Neuro-Oncology research group (07 - 005). Journal of neuro-oncology · 11 Sept 2026 PMID 42726379
  4. Long-term outcomes and patterns of failure in patients with thymic malignancies treated with surgery and radiation therapy. Cancer · 3 Sept 2026 PMID 42691203
  5. Real-world outcomes of radiotherapy timing in infants with medulloblastoma by molecular subtype: a single-center retrospective cohort study. Journal of neuro-oncology · 30 Jul 2026 PMID 42530653
  6. Radiotherapy for Soft-tissue Sarcoma of the Extremities: A 10-Year Analysis of Treatment Outcomes and Toxicity at a Large Sarcoma Centre. Anticancer research · 29 Jul 2026 PMID 42527052
  7. Treatment effect heterogeneity of radiotherapy in localized Ewing sarcoma: A secondary analysis of the EURO-E.W.I.N.G. 99 and Ewing 2008 trial. European journal of cancer (Oxford, England : 1990) · 30 May 2026 PMID 42218103
Prostate Cancer Radiotherapy (5)
  1. Local treatment vs. years of life lost in intermediate-risk prostate cancer. World journal of urology · 30 Oct 2026 PMID 42961521
  2. Global Perspectives on Radiotherapy Utilization for Pancreatic Ductal Adenocarcinoma. Journal of gastrointestinal cancer · 25 Sept 2026 PMID 42791432
  3. Synchronizing immunity and angiogenesis in lung adenocarcinoma: bridging biological synergy and clinical translation. Cancer biology & therapy · 8 Sept 2026 PMID 42708433
  4. Radiotherapy With Hyperthermia for Prostatic Ductal Adenocarcinoma: Primary and Salvage Cases. In vivo (Athens, Greece) · 28 Aug 2026 PMID 42665379
  5. High-dose radiotherapy in patients with high-risk prostate cancers treated with long-term androgen deprivation therapy (GETUG AFU 18): a randomised, phase 3 trial. The Lancet. Oncology · 24 Aug 2026 PMID 42636837

By study type

Clinical trials (3)
  1. High-dose radiotherapy in patients with high-risk prostate cancers treated with long-term androgen deprivation therapy (GETUG AFU 18): a randomised, phase 3 trial. The Lancet. Oncology · 24 Aug 2026 PMID 42636837
  2. Associations Between Cardiac Radiation Dose-Volume Metrics and Health-Related Quality of Life for Patients With Breast Cancer on the RadComp Trial. International journal of radiation oncology, biology, physics · 21 Jul 2026 PMID 42479004
  3. Camrelizumab, Apatinib, and Radiotherapy in Locally Advanced, Unresectable Hepatocellular Carcinoma: A Phase II Study. Clinical cancer research : an official journal of the American Association for Cancer Research · 30 Jun 2026 PMID 42377073
Observational studies and case reports (10)
  1. Psychosocial Distress and Radiation Treatment Interruptions in Patients With Cancer Using Machine Learning and Regression: Retrospective Cohort Study. JMIR cancer · 19 Oct 2026 PMID 42896154
  2. Nasal NUT carcinoma with repeated responses during multimodal treatment incorporating radiotherapy: A case report. Medicine · 19 Sept 2026 PMID 42760727
  3. Long-term outcomes after adjuvant radiotherapy in adult spinal ependymomas: a multicenter study by the trod Neuro-Oncology research group (07 - 005). Journal of neuro-oncology · 11 Sept 2026 PMID 42726379
  4. Cisplatin enhances radiation-induced apoptosis in peripheral lymphocytes of cancer patients: in vivo and in vitro findings. Radiation oncology (London, England) · 6 Sept 2026 PMID 42701199
  5. Long-term outcomes and patterns of failure in patients with thymic malignancies treated with surgery and radiation therapy. Cancer · 3 Sept 2026 PMID 42691203
  6. Radiotherapy With Hyperthermia for Prostatic Ductal Adenocarcinoma: Primary and Salvage Cases. In vivo (Athens, Greece) · 28 Aug 2026 PMID 42665379
  7. Real-world outcomes of radiotherapy timing in infants with medulloblastoma by molecular subtype: a single-center retrospective cohort study. Journal of neuro-oncology · 30 Jul 2026 PMID 42530653
  8. Radiotherapy for Soft-tissue Sarcoma of the Extremities: A 10-Year Analysis of Treatment Outcomes and Toxicity at a Large Sarcoma Centre. Anticancer research · 29 Jul 2026 PMID 42527052
  9. Does Breast Reconstruction Affect Radiation Therapy? Examining Device Type, Placement, and Dose Effects. Plastic and reconstructive surgery · 28 Jul 2026 PMID 42519937
  10. Efficacy analysis of first-line chemoimmunotherapy with or without radiotherapy in stage IVB esophageal squamous cell carcinoma: a real-world study. Future oncology (London, England) · 27 Jul 2026 PMID 42504461
Human data, design not indexed (16)
  1. Local treatment vs. years of life lost in intermediate-risk prostate cancer. World journal of urology · 30 Oct 2026 PMID 42961521
  2. "After radiation sessions, I sometimes feel weak and dizzy'': Experiences of Ghanaian women with breast cancer post radiotherapy. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 6 Oct 2026 PMID 42836877
  3. Oxygenation and Spatial Heterogeneity Shape Radiotherapy Protocol Ranking Through Phenotypic Adaptation. Bulletin of mathematical biology · 3 Oct 2026 PMID 42829426
  4. Maskless head and neck radiotherapy using surface-guided radiation therapy: initial clinical feasibility of real-time setup, intrafraction monitoring, and automatic beam-hold. Journal of applied clinical medical physics · 26 Sept 2026 PMID 42798136
  5. Global Perspectives on Radiotherapy Utilization for Pancreatic Ductal Adenocarcinoma. Journal of gastrointestinal cancer · 25 Sept 2026 PMID 42791432
  6. Perception of fall risk among cancer survivors receiving Radiotherapy/Chemotherapy in China: A latent profile analysis. PloS one · 24 Sept 2026 PMID 42784562
  7. Transoral Robotic Surgery (TORS) versus radical radiotherapy following neoadjuvant therapy for oropharyngeal carcinoma: a multicenter, real-world efficacy and safety analysis. Journal of robotic surgery · 19 Sept 2026 PMID 42762275
  8. Study of Adaptive Radiotherapy for High-Grade Glioma Based on Interfraction MRI. Cancer medicine · 1 Sept 2026 PMID 42675793
  9. Pretreatment Geriatric Nutritional Risk Index in RADPLAT-treated Patients With Oral Squamous Cell Carcinoma: A Pilot Study. In vivo (Athens, Greece) · 28 Aug 2026 PMID 42665408
  10. Should breast/thoracic wall and lymph node volumes have the same margin in hypofractionated radiotherapy? Biomedical physics & engineering express · 28 Aug 2026 PMID 42664997
  11. Age-dependent relative and absolute benefit of radiotherapy after breast-conserving surgery: a population-based analysis using SEER data. Breast cancer research and treatment · 23 Jul 2026 PMID 42493682
  12. A modality-agnostic coronary artery habitat model for cardiac sparing in radiotherapy. Medical physics · 22 Jul 2026 PMID 42482440
  13. Virtual Tumors Enable Prediction of Personalized Therapeutic Combinations for Non-Small Cell Lung Cancer. Cancer research · 24 Jun 2026 PMID 42341181
  14. Comparative Analysis of Acute Skin Reactions After Postmastectomy Photon and Intensity Modulated Proton Therapy. International journal of radiation oncology, biology, physics · 10 Jun 2026 PMID 42269789
  15. Impact of adjuvant breast radiotherapy on the risk and the survival of second primary lung cancer: a large population-based study. Japanese journal of clinical oncology · 2 Jun 2026 PMID 42228854
  16. Treatment effect heterogeneity of radiotherapy in localized Ewing sarcoma: A secondary analysis of the EURO-E.W.I.N.G. 99 and Ewing 2008 trial. European journal of cancer (Oxford, England : 1990) · 30 May 2026 PMID 42218103
Preclinical: animal, cell and lab studies (9)
  1. Synchronizing immunity and angiogenesis in lung adenocarcinoma: bridging biological synergy and clinical translation. Cancer biology & therapy · 8 Sept 2026 PMID 42708433
  2. Radiation-induced CD200+ tumor-associated macrophages suppress eosinophil-mediated antitumor immunity through CD200R signaling in hepatocellular carcinoma. Cellular & molecular immunology · 13 Aug 2026 PMID 42595852
  3. Targeting the METTL14/Wnt9a/β-catenin pathway with pharmacological inhibitors enhances radiotherapy and immunotherapy efficacy in non-small cell lung cancer. European journal of pharmacology · 6 Aug 2026 PMID 42562044
  4. Biomimetic nanovesicle mediated GSDME delivery reprograms the tumor immune microenvironment via pyroptosis to enhance radiotherapy. Journal of controlled release : official journal of the Controlled Release Society · 23 Jul 2026 PMID 42492635
  5. Dual-targeting pharmacological UFMylation inhibition reprograms tumor and immune microenvironments to achieve long-term glioblastoma regression. Signal transduction and targeted therapy · 19 Jul 2026 PMID 42472853
  6. Radiosensitization effect of PD-L1-targeted small molecules with direct antitumor activity on non-small cell lung Cancer. Bioorganic chemistry · 14 Jul 2026 PMID 42447749
  7. Hijacking radiotherapy-induced chemokines with self-assembled molecular decoys for glioblastoma radio-immunotherapy. Journal of controlled release : official journal of the Controlled Release Society · 2 Jul 2026 PMID 42392408
  8. Aptamer-tagged exosome-coated Bismuth ferrite-mesoporous silica nanoparticle for chemoradiotherapy and CT/MR imaging of non-small cell lung cancer. International journal of biological macromolecules · 24 Jun 2026 PMID 42342170
  9. Immune Checkpoint Blockade Augments Lymphodepleting Chemotherapy-Induced Antitumor Immunity by Expanding Effector CD8+ T-cell Clones. Cancer research · 22 Jun 2026 PMID 42329854
Unclassified: not yet indexed with MeSH (1)
  1. Radiotherapy in Thoracic NUT Carcinoma: A Pooled Analysis of Long-term Survivors and Clinical Outcome Heterogeneity. Archivos de bronconeumologia · 16 Sept 2026 PMID 42749595